Business Wire

AMAZON-PRIME-VIDEO

1.7.2021 17:37:14 CEST | Business Wire | Press release

Share
Japanese Record-Breaking Anime Blockbuster Film EVANGELION:3.0+1.01 THRICE UPON A TIME to Launch Exclusively on Amazon Prime Video on August 13th

Amazon Prime Video today announced the exclusive global premiere (outside of Japan) of the highly anticipated Japanese anime blockbuster EVANGELION:3.0+1.01 THRICE UPON A TIME on August 13th . EVANGELION:3.0+1.01 THRICE UPON A TIME is the fourth and final chapter of the new theatrical edition of Evangelion . The anime film – which is the highest-grossing in all movies by chief director Hideaki Anno and most-watched movie in Japanese theatres in 2021- is from directors Kazuya Tsurumaki , Katsuichi Nakayama and Mahiro Maeda as well as legendary creator, screenwriter and chief director Hideaki Anno (Shin Godzilla ). To celebrate the finale of the franchise, Prime Video will also release the three previous movies, EVANGELION:1.11 YOU ARE (NOT) ALONE., EVANGELION:2.22 YOU CAN (NOT) ADVANCE., EVANGELION:3.33 YOU CAN (NOT) REDO. to fans in more than 240 countries and territories.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210701005692/en/

The blockbuster franchise is a Japanese anime pop culture phenomenon based on the story of Evangelion, an artificial human and multipurpose humanoid weapon, and the Angels, an unknown life-form which takes place after the Earth has been shattered by a cataclysmic event. The film features all original voice actors including Megumi Ogata , Megumi Hayashibara , Yûko Miyamura and uses the latest imaging technology to showcase the personalities and relationships of its unique characters as they fight for survival. It will be dubbed in 10 languages including English, French, German, Portuguese, Spanish and Italian, and offer subtitles in 28 languages.

Since the TV series first aired in 1995, the Evangelion franchise has had a significant impact on Japanese pop culture and has elevated the anime genre worldwide. The legendary anime franchise was then reborn as a new movie series Evangelion: New Theatrical Edition in 2007 and this fourth and final movie released across theatres in Japan in March has gone on to break records, both for Hideaki Anno’s films and also as Japan’s most-watched theatrical movie of the year. EVANGELION:3.0+1.01 THRICE UPON A TIME on Amazon Prime Video will be the latest version of the film which includes revised scenes and is releasing across theatres now in Japan.

“The EVANGELION films have been thrilling fans for years and we know that there is a huge appetite around the world for the finale, said Brad Beale, Vice President, Worldwide Content Licensing Prime Video. “I’m excited for Prime members worldwide to finally have the opportunity to watch the anime masterpiece EVANGELION:3.0+1.01 THRICE UPON A TIME, as well as the three previous films.”

“I’d like to thank every Eva fan in the world for your continued support,” said Hideaki Anno, Creator, Screenwriter and Chief Director. “We were looking for the best way to offer the movie to fans overseas as early as possible in a challenging situation with movie theatres during COVID-19, and are happy to have found Prime Video as a partner to stream it globally. We highly recommend watching it on a big TV screen for the best viewing experience.”

ABOUT EVANGELION:3.0+1.01 THRICE UPON A TIME
The fourth and final installment of the Rebuild of Evangelion. Misato and her anti-Nerv group Wille arrive in Paris, a city now red from core-ization. Crew from the flagship Wunder land on a containment tower. They only have 720 seconds to restore the city. When a horde of Nerv Evas appear, Mari’s improved Eva Unit 8 must intercept. Meanwhile, Shinji, Asuka, and Rei (provisional name) wander around Japan.
Studio: khara, Inc.
Chief director: Hideaki Anno , Director: Kazuya Tsurumaki , Katsuichi Nakayama and Mahiro Maeda , Screenwriter: Hideaki Anno

ABOUT THE THREE PREVIOUS MOVIES

EVANGELION:1.11 YOU ARE (NOT) ALONE.
Scarred by the Second Impact, the Fourth Angel attacks Tokyo III and humanity's fate is left in the hands of Special Government Agency Nerv. Young Shinji Ikari is forced to pilot EVA-01. He and EVA-00 pilot Rei Ayanami are tasked to fight, but EVA-01 is damaged by the Sixth Angel. Misato Katsuragi draws up a plan to focus all of Japan's electricity into EVA-01's positron cannon to defeat the Angel.
Studio: khara, Inc.
Chief director: Hideaki Anno , Director: Masayuki and Kazuya Tsurumaki , Screenwriter: Hideaki Anno

EVANGELION:2.22 YOU CAN (NOT) ADVANCE.
Mari Illustrious-Makinami pilots Provisional Unit-05 to defeat the excavated Third Angel. Asuka Langley-Shikinami and EVA-02 defeat the Seventh Angel. The Eighth Angel appears and attacks Nerv HQ. EVA-03 is taken over by the Ninth Angel during testing and Shinji deploys to stop it, but learns Asuka is aboard. Gendo switches EVA-01's controls over to the Dummy System and begins fighting EVA-03.
Studio: khara, Inc.
Chief director: Hideaki Anno , Director: Masayuki and Kazuya Tsurumaki , Screenwriter: Hideaki Anno

EVANGELION:3.33 YOU CAN (NOT) REDO.
Shinji wakes after 14 years aboard the battleship AAA Wunder belonging to an anti-Nerv organization founded by former Nerv members. Shinji hears Rei's voice coming from EVA Mark.09, sent to rescue him, so he leaves Wunder and heads to Nerv. Kaworu Nagisa shows Shinji the transformed land. He learns that saving Rei triggered the Near Third Impact that caused the catastrophic damage to Earth.
Studio: khara, Inc.
Chief director: Hideaki Anno , Director: Masayuki , Mahiro Maeda and Kazuya Tsurumaki , Screenwriter: Hideaki Anno

EVANGELION:3.0+1.01 THRICE UPON A TIME will join the thousands of TV shows and movies in the Prime Video catalogue, including award-winning and critically acclaimed global Amazon Originals like Borat Subsequent Moviefilm, Tom Clancy's Jack Ryan, The Boys, Hunters, Fleabag, and The Marvelous Mrs. Maisel. All this is available on Prime Video at no extra cost for Prime members. Prime members will be able to watch EVANGELION:3.0+1.01 THRICE UPON A TIME anywhere and anytime on the Prime Video app for smart TVs, mobile devices, Fire TV, Fire TV stick, Fire tablets, Apple TV, and stream online. In the Prime Video app, Prime members can download episodes on their mobile devices and tablets and watch anywhere offline.

Amazon

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release

Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor

Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release

With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f

Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release

Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th

Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release

Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t

Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye